Before eating a healthy lunch with friends, Megan Fisher, a senior mechanical engineering major, slipped away quietly to check her insulin pump, a tedious chore she must perform before every meal.

A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, ...

(Reuters Health) – - When diabetic patients report problems with their insulin pumps, the pump manufacturers collect that information – but there’s no easy way for researchers to analyze the data ...

Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...

Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.

Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who used them.

According to the US FDA, at least 224 diabetes patients suffered from injuries linked to a glitch on t:connect iOS which shut down insulin pumps prematurely. isens usa from Unsplash Insulin pumps are ...

GAITHERSBURG, Maryland (Reuters) - Diabetics who wear insulin pumps appear more likely to experience problems from improper use than a device defect, members of a U.S. government advisory panel said ...

A large registry study in young people with type 1 diabetes found that hybrid closed-loop systems were linked to slightly better HbA1c and more time in the target glucose range than open-loop pump ...

Skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure, new research suggests. Insulin pump use is increasingly ...

The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny. The lapses ...